Gary Curhan, MD, Chief Medical Officer, OM1, Brand Insights Contributor
Advertisement
Articles by Gary Curhan, MD, Chief Medical Officer, OM1, Brand Insights Contributor
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Legal Risk in a Rumored AstraZeneca-BMS Deal: Q&A with Ron Lanton
2
FDA Grants Accelerated Approval to Tudriqev in Combination with Nivoumab for Advanced Melanoma
3
Your Questions Answered: The Biggest Pharma Stories of the Week of August 3-7, 2026
4
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals for $450 Million
5